Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Report Overview
The global radiopharmaceuticals market size was valued at USD 7.65 Billion in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 8.30% from 2026 to 2035 and is expected to reach USD 16.98 Billion by 2035. The radiopharmaceuticals industry is projected to expand steadily, driven by advances in the medical isotopes market and nuclear medicine market.
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
In May 2024, Nucleus RadioPharma collaborated with ARTBIO to produce Pb212-radiolabeled prostate cancer therapies, expediting clinical trials. These strategic alliances are aimed at strengthening radiopharmaceutical supply chains, fueling market expansion.
-
In April 2024, PharmaLogic inaugurated a radiopharmaceutical facility in Cincinnati, enhancing production and research. Such investments improve patient access to advanced radiopharmaceuticals, driving market growth.
-
Rising preference for precision medicine fuels demand for radiopharmaceuticals, enabling highly targeted cancer treatments. This enhances therapeutic efficacy, minimizes side effects, and drives industry innovation.
-
Technological progress in PET and SPECT imaging boosts early disease detection. Improved diagnostic accuracy increases demand for radiotracers, strengthening market expansion and driving research investments.
-
One of the major market trends include the rising adoption of alpha-emitting radiopharmaceuticals to offer superior tumor-killing potential with minimal damage to healthy tissues. They are in use for treating metastatic cancers and are reshaping treatment protocols and boosting market growth.
-
Companies are centralizing radiopharmaceutical production to streamline logistics and enhance regulatory compliance. This reduces costs, improves drug availability, and fosters market efficiency.
-
Key market players, including CDMOs, biotech firms, and pharmaceutical giants, are advancing radiopharmaceuticals through strategic partnerships, R&D investments, and acquisitions, shaping market competitiveness and treatment accessibility.
-
North America is expected to lead the market share with robust R&D, high adoption rates, and strong regulatory support. Europe follows with increasing investments, while Asia-Pacific shows rapid growth due to rising cancer prevalence and healthcare advancements.
Radiopharmaceuticals Market Companies
Key players in the market drive innovation through collaborations, acquisitions, and research, enhancing diagnostic imaging and expanding global access to advanced molecular imaging solutions. Some major players include:
Bayer AG - Bayer AG, founded in 1863 and headquartered in Leverkusen, Germany, is a global pharmaceutical leader. In the radiopharmaceuticals market, Bayer is pioneering targeted radionuclide therapies. In May 2024, it launched a Phase I trial for 225Ac-PSMA-Trillium, a next-generation alpha therapy for metastatic castration-resistant prostate cancer, reinforcing its commitment to precision oncology.
Jubilant Pharmova Limited - Jubilant Pharmova Limited, an Indian company, was established in 1978. It plays a significant role in the radiopharmaceuticals market through Jubilant Radiopharma, its U.S.-based business segment. With an extensive radiopharmacy network, it enhances nuclear medicine services, offering FDA-approved radiopharmaceuticals and diagnostic solutions. In October 2024, it partnered with Simplified Imaging Solutions to launch the first comprehensive nuclear medicine solution in the U.S., streamlining lab operations and improving efficiency.
Novartis AG - Founded in 1996 and headquartered in Basel, Switzerland, Novartis AG is a global pharmaceutical leader. It pioneered radioligand therapy (RLT), transforming cancer care. In March 2025, the FDA approved Pluvicto, an intravenous radioligand therapy for earlier use in prostate-specific membrane antigen (PSMA)-positive metastatic prostate cancer. This underscores Novartis’s commitment to advancing precision oncology and expanding treatment options for patients worldwide.
General Electric Company - General Electric Company, headquartered in Boston, Massachusetts, is a global leader in healthcare technology. In March 2025, GE HealthCare acquired full ownership of Nihon Medi-Physics, a leading radiopharmaceutical company in Japan. This acquisition strengthens its position in molecular imaging, enhancing diagnostic capabilities in neurology, cardiology, and oncology.
Other players in the market are Iso-Tex Diagnostics, Inc., Lantheus Holdings, Inc., Eli Lilly and Company, Siemens AG, Curium Pharma and Cardinal Health Inc. etc.
Radiopharmaceuticals Market Report Snapshots
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
In 2025, the radiopharmaceuticals market was valued at approximately USD 7.65 Billion which is likely to reach a value of USD 16.98 Billion by 2035.
The market is projected to grow at a compound annual growth rate (CAGR) of 8.30% during the forecast period from 2026 to 2035.
Key players in the market include Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens AG, Cardinal Health Inc., and Curium Pharma, among others.
Various factors driving the market growth are increasing demand for positron emission tomography and single-photon emission computed tomography imaging, rising cancer and cardiac disorder cases, and advancements in radiotracers.
North America is expected to lead the market in the forecast period.
Radiopharmaceuticals are essential in cancer diagnosis and therapy, neurology for brain imaging, and cardiology for heart function assessment, among other applications.
Hospitals, diagnostic imaging centers, research and academic institutes, and others are the major end-users in the radiopharmaceuticals market.
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
- Our Insights Store:
-
Industry Statistics
-
Procurement Insights
-
Consumer Insights
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124